Draft Action Plan-A Public Health Action Plan To Combat Antimicrobial Resistance, 14402-14403 [2011-6100]
Download as PDF
<![CDATA[
14402
Federal Register / Vol. 76, No. 51 / Wednesday, March 16, 2011 / Notices
Proposed Project
Annual Submission of the Ingredients
Added to, and the Quantity of Nicotine
Contained in, Smokeless Tobacco
Manufactured, Imported, or Packaged in
the U.S. (OMB No. 0920–0338, exp. 4/
30/2011)—Extension—Office on
Smoking and Health, National Center
for Chronic Disease Prevention and
Health Promotion (NCCDPHP), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
The Centers for Disease Control and
Prevention (CDC), Office on Smoking
and Health (OSH) has the primary
responsibility for the Department of
Health and Human Services (HHS)
smoking and health program. HHS’s
overall goal is to reduce death and
disability resulting from the use of
smokeless tobacco products and other
forms of tobacco use through programs
of information, education and research.
Since 1994, as required by the
Comprehensive Smokeless Tobacco
Education Act of 1986 (CSTHEA, 15
U.S.C. 4401 et seq., Public Law 99–252),
CDC has collected information about the
ingredients used in smokeless tobacco
products and their nicotine content.
Respondents are commercial smokeless
tobacco product manufacturers,
packagers, or importers (or their
representatives), who are required by
the CSTHEA to submit ingredient
reports to HHS on an annual basis.
Respondents are not required to
submit specific forms; however, they are
required to meet reporting guidelines
and to submit the ingredient report by
chemical name and Chemical Abstract
Service (CAS) Registration Number,
consistent with accepted reporting
practices for other companies currently
required to report ingredients added to
other consumer products. Typically,
respondents submit a summary report to
CDC with the ingredient information for
multiple products, or a statement that
there are no changes to their previously
submitted ingredient report.
Ingredient reports for new products
are due at the time of first importation.
Thereafter, ingredient reports are due
annually on March 31. Information is
submitted to OSH by mailing a written
report on the respondent’s letterhead, by
CD, three-inch floppy disk, or thumb
drive. Electronic mail submissions are
not accepted.
Upon receipt and verification of the
annual ingredient and nicotine data
reports, OSH issues a Certificate of
Compliance to the respondent. OSH also
uses the information to report to the
Congress (as deemed appropriate)
discussing the health effects of these
ingredients.
In this Extension request, there are no
changes to the estimated number of
respondents, the estimated burden per
response, or the information collection
methods. There are no costs to
respondents other than their time. The
total estimated annualized burden hours
are 18,843.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Smokeless Tobacco Manufacturers, Packagers, and Importers ................................................
11
1
1,713
Dated: March 10, 2011.
Carol E. Walker,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2011–6106 Filed 3–15–11; 8:45 am]
BILLING CODE 4163–18–P
HHS/CDC is publishing this notice on
behalf of the HHS Interagency Task
Force on Antimicrobial Resistance. The
draft Action Plan and supporting
documents can be found at https://
www.regulations.gov.
Written comments must be
received on or before April 15, 2011.
Comments received after April 15, 2011
will be considered to the fullest extent
possible.
DATES:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Draft Action Plan—A Public Health
Action Plan To Combat Antimicrobial
Resistance
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (DHHS).
ACTION: Notice of availability and
request for public comment.
jlentini on DSKJ8SOYB1PROD with NOTICES
AGENCY:
The Centers for Disease
Control and Prevention (CDC), located
within the Department of Health and
Human Services (HHS) is publishing
this notice requesting public comment
on the draft A Public Health Action Plan
to Combat Antimicrobial Resistance.
SUMMARY:
VerDate Mar<15>2010
16:56 Mar 15, 2011
Jkt 223001
Written comments may be
submitted to the following address:
Centers for Disease Control and
Prevention, National Center for
Emerging and Zoonotic Infectious
Diseases, Division of Healthcare Quality
Promotion, Office of Antimicrobial
Resistance, Attn: Antimicrobial
Resistance Action Plan, Docket No.
CDC–2011–0002, 1600 Clifton Rd., NE.,
Mailstop A–07, Atlanta, Georgia 30333.
You may also submit written
comments electronically to: https://
www.regulations.gov. All comments
received will be posted publicly without
change, including any personal or
proprietary information provided. To
download an electronic version of the
plan, access https://www.regulations.gov.
ADDRESSES:
[Docket No. CDC–2011–0002]
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
Written comments, identified by
Docket No. CDC–2011–0002 will be
available for public inspection Monday
through Friday, except for legal
holidays, from 9 a.m. until 5 p.m.,
Eastern Daylight Time, at 1600 Clifton
Road, NE., Atlanta, Georgia 30333.
Please call ahead to (404) 639–4000 and
ask for a representative from the Office
of Antimicrobial Resistance to schedule
your visit. Comments may also be
viewed at https://www.regulations.gov.
FOR FURTHER INFORMATION CONTACT:
Rachel Wolf, Centers for Disease Control
and Prevention, National Center for
Emerging and Zoonotic Infectious
Diseases, Division of Healthcare Quality
Promotion, Office of Antimicrobial
Resistance; 1600 Clifton Road, NE.,
Mailstop A–07, Atlanta, Georgia 30333,
(404) 639–4000.
SUPPLEMENTARY INFORMATION: The HHS
Interagency Task Force on
Antimicrobial Resistance (hereafter
referred to as the Task Force) was
created in 1999 to coordinate the
activities of Federal agencies in
addressing antimicrobial resistance (AR)
in recognition of the increasing
importance of AR as a public health
threat. The Task Force is co-chaired by
E:\FR\FM\16MRN1.SGM
16MRN1
Federal Register / Vol. 76, No. 51 / Wednesday, March 16, 2011 / Notices
jlentini on DSKJ8SOYB1PROD with NOTICES
the Centers for Disease Control and
Prevention (CDC), the Food and Drug
Administration (FDA), and the National
Institutes of Health (NIH). The Task
Force also includes the Agency for
Healthcare Research and Quality
(AHRQ), the Centers for Medicare and
Medicaid Services (CMS), the Health
Resources and Services Administration
(HRSA), the HHS Office of the Assistant
Secretary for Preparedness and
Response (HHS/ASPR), the Department
of Agriculture (USDA), the Department
of Defense (DoD), the Department of
Veterans Affairs (VA), and the
Environmental Protection Agency
(EPA).
In 2001, the Task Force developed an
initial Action Plan, outlining specific
issues, goals, and actions important for
addressing the problem of AR. This
document, entitled A Public Health
Action Plan to Combat Antimicrobial
Resistance, Part I: Domestic Issues,
reflected a broad-based consensus of
participating Federal agencies, which
was reached with individual input from
State and local health agencies,
universities, professional societies,
pharmaceutical companies, healthcare
delivery organizations, agricultural
producers, consumer groups, and other
members of the public. Continued
collaboration with these partners has
been vital to achieving successful
implementation of the Action Plan.
This draft document, A Public Health
Action Plan to Combat Antimicrobial
Resistance, is a revision of the 2001
interagency action plan. The revised
Action Plan provides an updated
blueprint for specific, coordinated
Federal action to address emerging
threats in AR. The document covers a
broad spectrum of AR issues, addressing
resistance in a wide range of pathogens
(bacteria, viruses, fungi, and parasites)
and settings (human medicine,
veterinary medicine, agriculture, animal
production, and others).
The Action Plan includes action items
organized into four focus areas:
Surveillance, Prevention and Control,
Research, and Product Development.
The Action Plan contains specific action
items, projects, and implementation
steps. Wherever possible, action items
are populated with specific projects or
implementation steps to provide greater
specificity for planned Federal
activities. The action items, projects,
VerDate Mar<15>2010
16:56 Mar 15, 2011
Jkt 223001
and implementation steps do not
represent an exhaustive list of activities.
Dated: March 11, 2011.
Tanja Popovic,
Deputy Associate Director for Science,
Centers for Disease Control and Prevention.
[FR Doc. 2011–6100 Filed 3–15–11; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Proposed Information Collection
Activity: Comment Request
Title: Personal Responsibility
Education Program (PREP) MultiComponent Evaluation.
OMB No.: New collection.
Description: The Family Youth
Services Bureau (HHS/ACF/ACYF/
FYSB) and the Office of Planning
Research and Evaluation (HHS/ACF/
OPRE) in the Administration for
Children and Families (ACF) are
proposing three data collection
activities to be undertaken for the
Personal Responsibility Education
Program (PREP) Multi-Component
Evaluation.
The impact study included in the
PREP Multi-Component Evaluation is a
random assignment evaluation which
will expand available evidence on
whether the replication of evidencebased effective programs, or the
substantial incorporation of elements of
these programs, funded as part of the
Personal Responsibility Education
Program, are effective at delaying sexual
activity, increasing condom or
contraceptive use for sexually active
youth, or reducing pregnancy among
youth. The evaluation will document
and test a range of pregnancy prevention
approaches in up to five program sites.
The findings from the evaluation will be
of interest to the general public, to
policy-makers, and to organizations
interested in teen pregnancy prevention.
This Federal Register Notice is to
notify the public regarding Data
Collection for the Baseline, Field
Collection, and In-Depth
Implementation Components of the
Impact and In-Depth Implementation
Evaluation of the Personal
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
14403
Responsibility Education Program
(PREP) Multi-Component Evaluation.
Field Collection: The field collection
activity involves the collection of
information from observations of
program activities and interviews with a
range of experts and persons involved
with programs about various aspects of
existing prevention programs and topics
the experts view as important to address
through evaluation. These data will be
used to help enhance decisions about
the types of programs to be evaluated in
the studies.
In-Depth Implementation: The
implementation data collection activity
as part of the in-depth implementation
portion of the PREP Multi-Component
Evaluation involves the collection of
information from program records and
site visits at two to three points in the
program implementation period.
Understanding the programs,
documenting their implementation and
context, and assessing fidelity of
implementation will allow for
description of each implemented
program and the treatment-control
contrast evaluated in each site. It will
also help in interpreting impact
findings, differences in impacts across
programs, and differences in impacts
across locations or population
subgroups.
Baseline: The baseline data collection
activity will present respondents with
carefully selected questions about
demographics and risk and protective
factors related to teen pregnancy. Also
proposed is a collection of school
records, performance, and program
participation for the youth. Information
from this data collection will be used to
perform meaningful analysis to
determine significant program effects.
Respondents:
Field Clearance: Researchers; Policy
Experts; State Level Coordinators;
Program Directors; Program Staff;
Program Participants; School
Administrators.
In-Depth Implementation: General
Staff; Community Members; Frontline
Staff; Participating Youth; and Control
Group Schools.
Baseline: Study participants (i.e.,
adolescents, and schools and
organizations responsible for
administrative data); Schools and
Organizations.
E:\FR\FM\16MRN1.SGM
16MRN1
]]>Agencies
[Federal Register Volume 76, Number 51 (Wednesday, March 16, 2011)]
[Notices]
[Pages 14402-14403]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-6100]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2011-0002]
Draft Action Plan--A Public Health Action Plan To Combat
Antimicrobial Resistance
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (DHHS).
ACTION: Notice of availability and request for public comment.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), located
within the Department of Health and Human Services (HHS) is publishing
this notice requesting public comment on the draft A Public Health
Action Plan to Combat Antimicrobial Resistance. HHS/CDC is publishing
this notice on behalf of the HHS Interagency Task Force on
Antimicrobial Resistance. The draft Action Plan and supporting
documents can be found at https://www.regulations.gov.
DATES: Written comments must be received on or before April 15, 2011.
Comments received after April 15, 2011 will be considered to the
fullest extent possible.
ADDRESSES: Written comments may be submitted to the following address:
Centers for Disease Control and Prevention, National Center for
Emerging and Zoonotic Infectious Diseases, Division of Healthcare
Quality Promotion, Office of Antimicrobial Resistance, Attn:
Antimicrobial Resistance Action Plan, Docket No. CDC-2011-0002, 1600
Clifton Rd., NE., Mailstop A-07, Atlanta, Georgia 30333.
You may also submit written comments electronically to: https://www.regulations.gov. All comments received will be posted publicly
without change, including any personal or proprietary information
provided. To download an electronic version of the plan, access https://www.regulations.gov.
Written comments, identified by Docket No. CDC-2011-0002 will be
available for public inspection Monday through Friday, except for legal
holidays, from 9 a.m. until 5 p.m., Eastern Daylight Time, at 1600
Clifton Road, NE., Atlanta, Georgia 30333. Please call ahead to (404)
639-4000 and ask for a representative from the Office of Antimicrobial
Resistance to schedule your visit. Comments may also be viewed at
https://www.regulations.gov.
FOR FURTHER INFORMATION CONTACT: Rachel Wolf, Centers for Disease
Control and Prevention, National Center for Emerging and Zoonotic
Infectious Diseases, Division of Healthcare Quality Promotion, Office
of Antimicrobial Resistance; 1600 Clifton Road, NE., Mailstop A-07,
Atlanta, Georgia 30333, (404) 639-4000.
SUPPLEMENTARY INFORMATION: The HHS Interagency Task Force on
Antimicrobial Resistance (hereafter referred to as the Task Force) was
created in 1999 to coordinate the activities of Federal agencies in
addressing antimicrobial resistance (AR) in recognition of the
increasing importance of AR as a public health threat. The Task Force
is co-chaired by
[[Page 14403]]
the Centers for Disease Control and Prevention (CDC), the Food and Drug
Administration (FDA), and the National Institutes of Health (NIH). The
Task Force also includes the Agency for Healthcare Research and Quality
(AHRQ), the Centers for Medicare and Medicaid Services (CMS), the
Health Resources and Services Administration (HRSA), the HHS Office of
the Assistant Secretary for Preparedness and Response (HHS/ASPR), the
Department of Agriculture (USDA), the Department of Defense (DoD), the
Department of Veterans Affairs (VA), and the Environmental Protection
Agency (EPA).
In 2001, the Task Force developed an initial Action Plan, outlining
specific issues, goals, and actions important for addressing the
problem of AR. This document, entitled A Public Health Action Plan to
Combat Antimicrobial Resistance, Part I: Domestic Issues, reflected a
broad-based consensus of participating Federal agencies, which was
reached with individual input from State and local health agencies,
universities, professional societies, pharmaceutical companies,
healthcare delivery organizations, agricultural producers, consumer
groups, and other members of the public. Continued collaboration with
these partners has been vital to achieving successful implementation of
the Action Plan.
This draft document, A Public Health Action Plan to Combat
Antimicrobial Resistance, is a revision of the 2001 interagency action
plan. The revised Action Plan provides an updated blueprint for
specific, coordinated Federal action to address emerging threats in AR.
The document covers a broad spectrum of AR issues, addressing
resistance in a wide range of pathogens (bacteria, viruses, fungi, and
parasites) and settings (human medicine, veterinary medicine,
agriculture, animal production, and others).
The Action Plan includes action items organized into four focus
areas: Surveillance, Prevention and Control, Research, and Product
Development. The Action Plan contains specific action items, projects,
and implementation steps. Wherever possible, action items are populated
with specific projects or implementation steps to provide greater
specificity for planned Federal activities. The action items, projects,
and implementation steps do not represent an exhaustive list of
activities.
Dated: March 11, 2011.
Tanja Popovic,
Deputy Associate Director for Science, Centers for Disease Control and
Prevention.
[FR Doc. 2011-6100 Filed 3-15-11; 8:45 am]
BILLING CODE 4163-18-P
